2023 Q2 Form 10-K Financial Statement
#000101738623000145 Filed on April 13, 2023
Income Statement
Concept | 2023 Q2 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $17.55K | $21.13K | $46.80K |
YoY Change | 124.91% | 369.56% | 56.01% |
Cost Of Revenue | $4.732K | $5.710K | $12.67K |
YoY Change | 128.82% | 335.88% | 26.74% |
Gross Profit | $12.82K | $15.42K | $34.13K |
YoY Change | 123.5% | 383.39% | 70.65% |
Gross Profit Margin | 73.04% | 72.98% | 72.92% |
Selling, General & Admin | $112.6K | $209.7K | $504.3K |
YoY Change | 8.6% | 479.46% | 320.27% |
% of Gross Profit | 878.14% | 1359.6% | 1477.69% |
Research & Development | $5.876K | $3.120K | $12.07K |
YoY Change | 10.83% | -56.49% | 20.74% |
% of Gross Profit | 45.84% | 20.23% | 35.38% |
Depreciation & Amortization | $240.00 | $220.00 | $536.00 |
YoY Change | 118.18% | ||
% of Gross Profit | 1.87% | 1.43% | 1.57% |
Operating Expenses | $118.4K | $212.8K | $516.4K |
YoY Change | 8.7% | 390.82% | 297.22% |
Operating Profit | -$105.6K | -$197.4K | -$482.3K |
YoY Change | 2.33% | 391.41% | 338.42% |
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $530.00 | -$310.00 | $1.340K |
YoY Change | -56.56% | ||
Pretax Income | -$105.1K | -$197.7K | -$480.9K |
YoY Change | 3.03% | 392.3% | 337.21% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$105.1K | -$197.7K | -$480.9K |
YoY Change | 3.03% | 392.3% | 342.38% |
Net Earnings / Revenue | -598.78% | -935.45% | -1027.55% |
Basic Earnings Per Share | $0.00 | $0.00 | |
Diluted Earnings Per Share | $0.00 | $0.00 | $0.00 |
COMMON SHARES | |||
Basic Shares Outstanding | 111.9M shares | 111.8M shares | 111.9M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q2 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $10.52K | $138.3K | $138.3K |
YoY Change | -94.66% | -35.37% | -34.13% |
Cash & Equivalents | $10.52K | $138.3K | |
Short-Term Investments | |||
Other Short-Term Assets | $1.170K | $30.67K | $30.67K |
YoY Change | |||
Inventory | $16.40K | $27.55K | $27.55K |
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $28.09K | $196.5K | $196.5K |
YoY Change | -87.9% | -22.62% | -21.38% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $3.978K | $4.470K | $4.470K |
YoY Change | 20.22% | ||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $3.978K | $4.470K | $4.470K |
YoY Change | 20.22% | ||
TOTAL ASSETS | |||
Total Short-Term Assets | $28.09K | $196.5K | $196.5K |
Total Long-Term Assets | $3.978K | $4.470K | $4.470K |
Total Assets | $32.07K | $201.0K | $201.0K |
YoY Change | -86.39% | -20.86% | -19.6% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $19.30K | $1.565K | $1.570K |
YoY Change | 1421.69% | 34.91% | |
Accrued Expenses | $11.06K | $13.19K | $10.83K |
YoY Change | 2.7% | ||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $55.69K | $25.59K | $25.59K |
YoY Change | 281.99% | 631.8% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $55.69K | $25.59K | $25.59K |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $55.69K | $25.59K | $25.59K |
YoY Change | 281.99% | 631.8% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$1.156M | -$936.7K | |
YoY Change | 87.24% | 105.53% | |
Common Stock | $86.85K | $111.8K | |
YoY Change | -22.28% | -1.32% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$23.63K | $175.4K | $175.4K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $32.07K | $201.0K | $201.0K |
YoY Change | -86.39% | -20.86% | -19.6% |
Cashflow Statement
Concept | 2023 Q2 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$105.1K | -$197.7K | -$480.9K |
YoY Change | 3.03% | 392.3% | 342.38% |
Depreciation, Depletion And Amortization | $240.00 | $220.00 | $536.00 |
YoY Change | 118.18% | ||
Cash From Operating Activities | -$39.45K | -$68.72K | -$301.9K |
YoY Change | -49.18% | 79.14% | 201.89% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $1.280K | $5.820K |
YoY Change | -100.0% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | $0.00 | -$1.280K | -$5.818K |
YoY Change | -100.0% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $225.0K | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | 102.0K | $232.0K |
YoY Change | -100.0% | 10100.0% | 5.46% |
NET CHANGE | |||
Cash From Operating Activities | -39.45K | -68.72K | -301.9K |
Cash From Investing Activities | 0.000 | -1.280K | -$5.818K |
Cash From Financing Activities | 0.000 | 102.0K | $232.0K |
Net Change In Cash | -39.45K | 32.00K | -$75.71K |
YoY Change | -221.57% | -185.65% | -163.09% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$39.45K | -$68.72K | -$301.9K |
Capital Expenditures | $0.00 | $1.280K | $5.820K |
Free Cash Flow | -$39.45K | -$70.00K | -$307.7K |
YoY Change | -46.84% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001703157 | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2021Q4 | us-gaap |
Deposit Assets
DepositAssets
|
usd | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
usd | |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
usd | |
CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
usd | |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2021 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
usd | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2021 | scth |
Cancellation Of Common Shares
CancellationOfCommonShares
|
usd | |
CY2022 | scth |
Cancellation Of Common Shares
CancellationOfCommonShares
|
usd | |
CY2021 | us-gaap |
Depreciation
Depreciation
|
usd | |
CY2021 | scth |
Gain Loss On Disposition Of Assets2
GainLossOnDispositionOfAssets2
|
usd | |
CY2021 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
usd | |
CY2021 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
usd | |
CY2021 | us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
usd | |
CY2021 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
usd | |
CY2021 | us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
usd | |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2022Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
usd | |
CY2021Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
usd | |
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
000-55927 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
SecureTech Innovations, Inc. | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
WY | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
82-0972782 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2355 Highway 36 West | |
CY2022 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 400 | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Roseville | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MN | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
55113 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
(651) 317-8990 | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
317-8990 | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
31749800 | usd |
CY2023Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
111850513 | shares |
CY2022 | dei |
Auditor Name
AuditorName
|
M&K CPAS, PLLC | |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
2738 | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Houston, TX | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
138318 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
214026 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
27549 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
39975 | usd |
CY2022Q4 | us-gaap |
Deposit Assets
DepositAssets
|
30674 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
196541 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
254001 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4470 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
201011 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
254001 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1565 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1160 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
13194 | usd |
CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
5679 | usd |
CY2022Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
5153 | usd |
CY2021Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
2337 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
25591 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3497 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
25591 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
3497 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
111839085 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
111839085 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
113336300 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
113336300 | shares |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
111839 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
113336 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1000239 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
592899 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-936658 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-455731 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
175420 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
250504 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
201011 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
254001 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
46803 | usd |
CY2021 | us-gaap |
Revenues
Revenues
|
31713 | usd |
CY2022 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
12674 | usd |
CY2021 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
8915 | usd |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
34129 | usd |
CY2021 | us-gaap |
Gross Profit
GrossProfit
|
22798 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
504316 | usd |
CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
124267 | usd |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
12074 | usd |
CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7245 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
516390 | usd |
CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
131511 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-482261 | usd |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-108713 | usd |
CY2022 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
1335 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-480926 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-108713 | usd |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
111929796 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
156034210 | shares |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
135967 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
222250 | usd |
CY2021Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.20 | |
CY2021 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
1000 | usd |
CY2021 | us-gaap |
Profit Loss
ProfitLoss
|
-108713 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
250504 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
225001 | usd |
CY2022Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.50 | |
CY2022 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
7000 | usd |
CY2022 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
173842 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-480927 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
175420 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-480926 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-108713 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
536 | usd |
CY2022 | scth |
Gain Loss On Disposition Of Assets2
GainLossOnDispositionOfAssets2
|
812 | usd |
CY2022 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
173842 | usd |
CY2022 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
12426 | usd |
CY2021 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
9018 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
405 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-175 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
13194 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
5679 | usd |
CY2022 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
-30674 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
2816 | usd |
CY2021 | us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
842 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-301891 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-99028 | usd |
CY2022 | us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
5818 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5818 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
225001 | usd |
CY2021 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
222250 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
7000 | usd |
CY2021 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
1000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
232001 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
223250 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-75708 | usd |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
124222 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
214026 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
89804 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
138318 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
214026 | usd |
CY2022 | scth |
Stock Cancelled1
StockCancelled1
|
1700 | usd |
CY2021 | scth |
Stock Cancelled1
StockCancelled1
|
58000 | usd |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84A_eus-gaap--UseOfEstimates_z2y1ugT9Tdj" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities depends on future events, the preparation of financial statements for a period necessarily involves the use of estimates made using careful judgment. Actual results may vary from these estimates.</p> <hr style="border-width: 0; margin: 14pt 0 0; height: 0; width: 0"/> | |
CY2022 | us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.762 | pure |
CY2022 | us-gaap |
Fiscal Period
FiscalPeriod
|
<p id="xdx_846_eus-gaap--FiscalPeriod_ziGDDIqDI7z4" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>Fiscal Year</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">The Company elected December 31st for its fiscal year-end.</p> <p style="font: 10pt Times New Roman; margin: 0"> </p> | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-936658 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
196698 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
95704 | usd |
CY2022Q4 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
2185 | usd |
CY2021Q4 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
1955 | usd |
CY2022Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
25364 | usd |
CY2021Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
38020 | usd |
CY2022Q4 | us-gaap |
Inventory Gross
InventoryGross
|
27549 | usd |
CY2021Q4 | us-gaap |
Inventory Gross
InventoryGross
|
39975 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
27549 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
39975 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
196698 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
95704 | usd |
CY2022Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
936658 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
188785 | shares |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
225001 | usd |
CY2022 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
14000 | shares |
CY2022 | us-gaap |
Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
|
14000 | shares |
CY2022 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
7000 | usd |
CY2022 | us-gaap |
Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
|
1700000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
111839085 | shares |
CY2022 | scth |
Warrants Disclosure
WarrantsDisclosure
|
<p id="xdx_802_ecustom--WarrantsDisclosure_zqBELsV8MK57" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>NOTE 6 – WARRANTS</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">As of December 31, 2022, the Company had no warrants issued and outstanding.</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000"><i>Warrant Issuances, Exercises, and Expirations</i></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000">Private Placement Warrant Issuances</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000">During the fiscal year ended December 31, 2020, the Company undertook a private placement of its securities through a private placement Unit offering. Each Unit included one share of the Company’s common stock and four stock purchase warrants with incremental exercise prices and expiration dates. An aggregate of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20201231_zmsE7pek1Dz9">1,757,200</span> stock purchase warrants were issued under this offering, which was closed on June 30, 2020.</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000">The warrants were valued using the Black-Scholes model with a <span id="xdx_905_eus-gaap--AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherFairValueVolatilityRate_dp_c20210101__20211231_znTpA2mtlcF4">53.0%</span> volatility rate and discount rates ranging from<span id="xdx_90C_ecustom--DiscountRateMinimum_dp_c20210101__20211231_zLeheOjnsDIl"> 0.16%</span> - <span id="xdx_900_ecustom--DiscountRateMaximum_dp_c20210101__20211231_zYfHRXAhuLce">0.21%</span> for a total fair value of $<span id="xdx_906_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20211231_zvZx5r2ehiac">19,257</span>.</p> <p style="font: 10pt Times New Roman; margin: 0; color: #000000"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000">Warrant Expirations</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000">During the fiscal year ended December 31, 2022, an aggregate of 1,303,900 warrants expired with an average exercise price of $0.35 a share.</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">A summary of the warrant activity for the fiscal year ended December 31, 2022, is as follows:</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--ScheduleOfStockholdersEquityNoteWarrantsActivityTextBlock_za0pSIaa41ek" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Warrants Activity (Details)"> <tr style="vertical-align: bottom"> <td colspan="3" style="text-align: center"><b style="display: none">Warrant Activity</b></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman; margin: 0; text-align: center"> </p><p style="font: 10pt Times New Roman; margin: 0; text-align: center"> </p><p style="font: 10pt Times New Roman; margin: 0; text-align: center"> </p><p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>Weighted-Average</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>Exercise Price</b></p></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>Weighted-Average</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>Remaining</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>Contractual Term</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>(Years)</b></p></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman; margin: 0; text-align: center"> </p><p style="font: 10pt Times New Roman; margin: 0; text-align: center"> </p><p style="font: 10pt Times New Roman; margin: 0; text-align: center"> </p><p style="font: 10pt Times New Roman; margin: 0; text-align: center"> </p><p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>Aggregate</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>Intrinsic Value</b></p></td></tr> <tr id="xdx_40D_ecustom--ClassOfWarrantNumberOfSharesAbstract_iB_zKyFZPDpaWYg" style="display: none; vertical-align: bottom"> <td colspan="3" style="text-align: justify"><b>Warrants</b></td><td><b> </b></td> <td colspan="3" style="text-align: right"><b> </b></td><td><b> </b></td> <td colspan="3" style="text-align: right"><b> </b></td><td><b> </b></td> <td colspan="3" style="text-align: right"><b> </b></td><td><b> </b></td> <td colspan="3" style="text-align: right"><b> </b></td></tr> <tr id="xdx_407_ecustom--ClassOfWarrantWeightedAverageExercisePriceAbstract_iB_zktaR7721s2a" style="display: none; vertical-align: bottom"> <td colspan="3" style="text-align: justify"><b>Weighted-Average Exercise Prices</b></td><td><b> </b></td> <td colspan="3" style="text-align: right"><b> </b></td><td><b> </b></td> <td colspan="3" style="text-align: right"><b> </b></td><td><b> </b></td> <td colspan="3" style="text-align: right"><b> </b></td><td><b> </b></td> <td colspan="3" style="text-align: right"><b> </b></td></tr> <tr id="xdx_40A_ecustom--ClassOfWarrantWeightedAverageRemainingContractualTermAbstract_iB_zAIbLEERpKG3" style="display: none; vertical-align: bottom"> <td colspan="3" style="text-align: justify"><b>Weighted-Average Remaining Contractual Term (Years)</b></td><td><b> </b></td> <td colspan="3" style="text-align: right"><b> </b></td><td><b> </b></td> <td colspan="3" style="text-align: right"><b> </b></td><td><b> </b></td> <td colspan="3" style="text-align: right"><b> </b></td><td><b> </b></td> <td colspan="3" style="text-align: right"><b> </b></td></tr> <tr id="xdx_408_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_iB_z4NurxYEh32i" style="display: none; vertical-align: bottom"> <td colspan="3" style="text-align: justify"><b>Aggregate Intrinsic Value</b></td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify">Outstanding on January 1, 2022</p></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iSP1custom--ClassOfWarrantNumberOfSharesAbstract_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zCuY2lutdOC" style="width: 16%; text-align: right">1,317,900</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--TemporaryEquityRedemptionPricePerShare_iSP1custom--ClassOfWarrantWeightedAverageExercisePriceAbstract_uUSDPShares_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zQfThhVgIon5" style="width: 16%; text-align: right">0.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_iP1custom--ClassOfWarrantWeightedAverageRemainingContractualTermAbstract_dtY_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zDWgWdqNmyBl" style="width: 15%; text-align: right" title="Weighted-Average Remaining Contractual Term, beginning">0.3</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iSP1us-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zSXGnOCwlDK" style="width: 15%; text-align: right">1,124,465</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify">Issued</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--WarrantsIssuedDuringPeriod_iP1custom--ClassOfWarrantNumberOfSharesAbstract_d0_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_ze1SYpa6kD87" style="text-align: right" title="Issued">— </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--WarrantsGrantedDuringPeriod_iP1custom--ClassOfWarrantWeightedAverageExercisePriceAbstract_d0_uUSDPShares_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zUPp3cqgfanl" style="text-align: right" title="Issued">— </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">— </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">— </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify">Exercised</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--WarrantsExcercisedDuringPeriod_iP1custom--ClassOfWarrantNumberOfSharesAbstract_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zvDGXPnCD6e1" style="text-align: right" title="Exercised">(14,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_ecustom--WarrantsExercisedDuringPeriod_iP1custom--ClassOfWarrantWeightedAverageExercisePriceAbstract_uUSDPShares_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_z0ZPHGvOSSLh" style="text-align: right" title="Exercised">0.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">— </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_iP1us-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zt9c1L7G4Ak" style="text-align: right">42,700</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify">Expired</p></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--WarrantsCanceledDuringPeriod_iP1custom--ClassOfWarrantNumberOfSharesAbstract_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zlO6BqloCtLa" style="border-bottom: Black 1pt solid; text-align: right" title="Expired">(1,303,900</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_ecustom--WarrantsForfeitedcanceledDuringPeriod_iP1custom--ClassOfWarrantWeightedAverageExercisePriceAbstract_uUSDPShares_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zEBW4ptPUdZ6" style="border-bottom: Black 1pt solid; text-align: right" title="Expired">0.35</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">— </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_iP1us-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zoicUeG8QASe" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"> 4,172,480</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify">Outstanding on December 31, 2022</p></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iEP1custom--ClassOfWarrantNumberOfSharesAbstract_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zPst6QjbxKyf" style="border-bottom: Black 2.5pt double; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl0439">—</span> </b></td><td style="padding-bottom: 2.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 2.5pt"><b> </b></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><b> </b></td><td id="xdx_987_eus-gaap--TemporaryEquityRedemptionPricePerShare_iEP1custom--ClassOfWarrantWeightedAverageExercisePriceAbstract_uUSDPShares_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zBExZxiEHrzf" style="border-bottom: Black 2.5pt double; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl0440">—</span> </b></td><td style="padding-bottom: 2.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 2.5pt"><b> </b></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><b> </b></td><td id="xdx_98C_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTermEnd_iP1custom--ClassOfWarrantWeightedAverageRemainingContractualTermAbstract_dtY_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zCAlEKqeVWxh" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted-Average Remaining Contractual Term, ending"><span style="-sec-ix-hidden: xdx2ixbrl0442"><b>— </b></span></td><td style="padding-bottom: 2.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iEP1us-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zcn03HJtHPA6" style="border-bottom: Black 2.5pt double; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl0443">—</span> </b></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based on warrants with an exercise price less than the Company’s stock price of <span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20221231_zbNIUmxcslwk">$3.55</span> (based on the closing price quoted on the OTC Pink Tier of the OTC Market Group, Inc.) on December 31, 2022, which the warrant holders would have received had those warrant holders exercised their warrants as of that date.</p> <p style="font: 10pt Times New Roman; margin: 0"> </p> | |
CY2020Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
1757200 | shares |
CY2021 | us-gaap |
Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Other Fair Value Volatility Rate
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherFairValueVolatilityRate
|
0.530 | pure |
CY2021 | scth |
Discount Rate Minimum
DiscountRateMinimum
|
0.0016 | pure |
CY2021 | scth |
Discount Rate Maximum
DiscountRateMaximum
|
0.0021 | pure |
CY2021Q4 | us-gaap |
Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
|
19257 | usd |
CY2022Q4 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
3.55 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1500000 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.35 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
3.160 | pure |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
|
0.028 | pure |
CY2022 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
173842 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
11428 | shares |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
20000 | usd |
CY2023Q1 | us-gaap |
Share Price
SharePrice
|
1.75 |